British diagnostics company FluoretiQ Ltd was selected as start-up pitch winner during the 4th annual AMR conference on 27th August. In an interview Neciah…
BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics At the end of the 4th AMR Conference…
Epidermicins – a new family of antimicrobial proteins with excellent clinical potential
bye bye
Inhibition of AgrA-mediated virulence factor expression in MRSA: a viable, non-lethal, treatment option.
AMR Stakeholder Profile FIND (Foundation for Innovative New Diagnostics) Focus area/active in: Diagnostics Company/Organisation type: Foundation About:FIND is a global non-profit organization dedicated to…
Dr Manica Balasegaram, GARDP Executive Director, spoke at the opening of BIOCOM’s 4th AMR Conference on the importance of learning lessons from COVID-19 to…
Development of a Small Molecule Inhibitor of Salmonella Invasion-related Pathogenicity
BACTERIOLYTIC ENZYME AURESINE a new, selective weapon against Staphylococcus